Month: November 2017

Mergers & Acquisitions

Canopy Growth and Constellation finalize previously announced strategic transaction

November 2, 2017 0

Canopy Growth and Constellation finalize previously announced strategic transaction Canada NewsWire SMITHS FALLS, ON, Nov. 2, 2017 SMITHS FALLS, ON , Nov. 2, 2017 /CNW/ – Canopy Growth Corporation (TSX:WEED) (“Canopy Growth” or the “Company”) has completed the previously announced transaction that saw Constellation Brands (“Constellation”) (NYSE: STZ and STZ.B) strategically invest CDN $245 million in Canopy Growth in exchange for 9.9% equity in the Company following completion of the investment. […]

Technicals

Hyatt (H) Beats on Earnings & Revenue Estimates in Q3

November 2, 2017 0

Hyatt Hotels Corporation H is a leading global hospitality company and operates under a number of leading brands. The company has a significant presence in major hospitality markets across the world. The company has an industry-leading guest loyalty program — Hyatt Gold Passport program — which serves millions of members worldwide […]

Stock Analysts

5 Biotech and Pharma Stocks with Key FDA Catalysts this November

November 2, 2017 0

The FDA, which approved 22 novel drugs last year, has given its approval to 35 drugs so far in 2017 including a key approval in October – Gilead Sciences’s GILD Yescarta, a cell-based gene therapy for the treatment of adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. This makes Yescarta the second gene therapy to gain FDA approval, the first being Novartis AG’s NVS Kymriah. Kymriah was approved in late August 2017 for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (“ALL”). […]

Stock Analysts

Willis Towers (WLTW) Q3 Earnings Lag Estimates, Revenues Top

November 2, 2017 0

Willis Towers Watson Public Limited Company WLTW reported third-quarter 2017 adjusted net income of $1.12 per share that missed the Zacks Consensus Estimate of $1.13 by 0.9%. However, the bottom line improved 7.7% year over year. Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise Willis Towers Watson Public Limited Company Price, Consensus and EPS Surprise | Willis Towers Watson Public Limited Company Quote Increase in revenues as well as a solid segmental performance were responsible for this upside. […]

Stock Analysts

Key Predictions for Q3 Earnings Reports of ROCK, IBP & USCR

November 2, 2017 0

We are well past the half-way mark of the Q3 reporting cycle, with more than 327 S&P 500 companies having already reported results till Nov 1. These companies account for 71.2% of the index’s total market capitalization, with 74.9% topping EPS (earnings per share) estimates and 65.7% coming in ahead of top-line expectations. We currently anticipate that earnings and revenues of all the S&P 500 stocks would be up 5.6% and 5.5%, respectively, on a year-over-year basis. […]